Presented at the SYNChronicity Conference by the Hepatic Innovation Team Collaborative Leadership Team of the Veterans Health Administration.
Presented at the SYNChronicity Conference.
This presentation examines the development of a microelimination plan.
Presented at the SYNChronicity Conference.
The Implementing Transmucosal Buprenorphine for Treatment of Opioid Use Disorder best practice document was designed to fill information gaps and provide guidance.
Presented at the SYNChronicity Conference, developed by the Hepatitis C Mentoring and Support Group (HCMSG).
This presentation from the SYNChronicity conference examines the effects of opioid use on HCV.
This recording of a presentation by CDC’s Dr. Sarah Schillie explores CDC’s newest HCV screening recommendations.
Learn more about model practices for increasing HCV screening and linkage to care in a variety of practice settings.
HealthHCV’s Fourth Annual State of HCV Care National Survey evaluates the latest impacts on HCV screening, treatment, and related support services.
An Initiative of HealthHIV
1630 Connecticut Ave. NW, Suite 500
Washington, DC 20009
202-232-6749 | [email protected]
© Copyright 2025 HealthHIV. All rights reserved. | Privacy Policy | Site Map